CINECA IRIS Institutional Research Information System

ROFI, ELEONORA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.771
EU - Europa 703
AS - Asia 300
AF - Africa 79
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 8
SA - Sud America 3
Totale 2.873
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.732
IT - Italia 319
CN - Cina 141
SE - Svezia 122
SG - Singapore 90
BG - Bulgaria 78
CI - Costa d'Avorio 58
DE - Germania 53
GB - Regno Unito 49
CA - Canada 38
VN - Vietnam 31
AT - Austria 30
FR - Francia 13
SN - Senegal 12
IN - India 10
NL - Olanda 10
EU - Europa 8
NG - Nigeria 8
AU - Australia 7
ES - Italia 6
HK - Hong Kong 6
JP - Giappone 6
KR - Corea 6
PL - Polonia 5
BE - Belgio 3
BR - Brasile 3
FI - Finlandia 3
CH - Svizzera 2
LK - Sri Lanka 2
LV - Lettonia 2
NZ - Nuova Zelanda 2
RO - Romania 2
RU - Federazione Russa 2
TR - Turchia 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
HR - Croazia 1
IL - Israele 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
NO - Norvegia 1
UZ - Uzbekistan 1
Totale 2.873
Salva come PNG Salva come JPEG
Città #
Fairfield 233
Woodbridge 218
Houston 162
Chandler 139
Ashburn 126
Seattle 110
Cambridge 82
Serra 78
Sofia 78
Wilmington 77
Ann Arbor 72
New York 59
Abidjan 58
Pisa 56
Florence 43
Princeton 42
Boardman 33
Beijing 31
Lawrence 31
Ottawa 31
Vienna 29
Frankfurt am Main 26
London 26
Medford 23
Nanjing 19
Dearborn 18
Des Moines 16
Dong Ket 15
Boulder 14
Singapore 14
Dakar 12
Chiesina Uzzanese 11
Rome 11
Washington 10
Redwood City 9
San Diego 9
Hefei 8
Lagos 8
Kunming 7
Bremen 6
Hong Kong 6
Iowa City 6
Los Angeles 6
Milan 6
San Francisco 6
Changsha 5
Columbus 5
Guangzhou 5
Ogden 5
Phoenix 5
Shanghai 5
Turin 5
Kilburn 4
Chengdu 3
Dallas 3
Genoa 3
Hebei 3
Jiaxing 3
Lancaster 3
Monza 3
Nanchang 3
Norwalk 3
Pistoia 3
Shenyang 3
Toronto 3
Warsaw 3
Zhengzhou 3
Amsterdam 2
Baotou 2
Bientina 2
Bitritto 2
Brussels 2
Camaiore 2
Chicago 2
Esslingen am Neckar 2
Hyderabad 2
Kolkata 2
Lucca 2
Montréal 2
Nuremberg 2
Nutley 2
Perth 2
Philadelphia 2
Polska 2
Prato 2
Riga 2
Santiago De Compostela 2
Savona 2
Seoul 2
Tappahannock 2
Tianjin 2
Vicopisano 2
Auckland 1
Azor 1
Bari 1
Bellingham 1
Berlin 1
Bonita Springs 1
Bucharest 1
Bukhara 1
Totale 2.219
Salva come PNG Salva come JPEG
Nome #
PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC 240
null 142
Early changes in plasma DNA levels of mutant KRAS as a sensitive marker of response to chemotherapy in pancreatic cancer 129
Overexpression of TK1 and CDK9 in plasma-derived exosomes is associated with clinical resistance to CDK4/6 inhibitors in metastatic breast cancer patients 122
Patients with NSCLC may display a low ratio of p.T790M vs. activating EGFR mutations in plasma at disease progression: implications for personalised treatment 120
Clinical pharmacology of intravitreal anti-VEGF drugs 112
The amount of activating EGFR mutations in circulating cell-free DNA is a marker to monitor osimertinib response 112
Concise Review: Chronic Myeloid Leukemia: Stem Cell Niche and Response to Pharmacologic Treatment 109
Pharmacogenetics and metabolism from science to implementation in clinical practice: the example of dihydropyrimidine dehydrogenase. 107
Pharmacokinetic Markers of 5-Fluorouracil Toxicity in Clinical Trials and Real World 106
AR-V7 and AR-FL expression is associated with clinical outcome: a translational study in patients with castrate resistant prostate cancer 102
Detection of ALK and KRAS Mutations in Circulating Tumor DNA of Patients With Advanced ALK-Positive NSCLC With Disease Progression During Crizotinib Treatment 101
Pharmacogenetics of CYP2D6 and tamoxifen therapy: Light at the end of the tunnel? 101
Implications of KRAS mutations in acquired resistance to treatment in NSCLC 99
The emerging role of liquid biopsy in diagnosis, prognosis and treatment monitoring of pancreatic cancer 95
From the beginning to resistance: study of plasma monitoring and resistance mechanisms in a cohort of patients treated with osimertinib for advanced T790M-positive NSCLC 95
EGFR-TKIs in non-small-cell lung cancer: Focus on clinical pharmacology and mechanisms of resistance 91
The increase in activating EGFR mutation in plasma is an early biomarker to monitor response to osimertinib: a case report 90
Pharmacogenetics of androgen signaling in prostate cancer: focus on castration resistance and predictive biomarkers of response to treatment 89
Primary resistance to osimertinib due to SCLC transformation: Issue of T790M determination on liquid re-biopsy 79
Comprehensive pharmacogenetic analysis of DPYD, UGT, CDA, and ABCB1 polymorphisms in pancreatic cancer patients receiving mFOLFIRINOX or gemcitabine plus nab-paclitaxel 79
Rechallenge for Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan: A Phase 2 Single-Arm Clinical Trial 78
Dabrafenib treatment in a patient with BRAF V600E ganglioglioma: circulating exosome-derived cancer RNA supports treatment choice and clinical monitoring 77
Erratum: Clinical pharmacology of monoclonal antibodies targeting PD-1 axis in urothelial cancers 70
Gemcitabine plus nab-paclitaxel induces PD-L1 mRNA expression in plasma-derived microvesicles in pancreatic cancer 68
Endothelial nitric oxide synthase c.-813C>T predicts for proteinuria in metastatic breast cancer patients treated with bevacizumab-based chemotherapy 65
null 60
Reply to Ugo De Giorgi, Vincenza Conteduca, and Emanuela Scarpi's Letter to the Editor re: Marzia Del Re, Elisa Biasco, Stefania Crucitta, et al. The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients. Eur Urol 2017;71:680–7 56
Concise Review: Resistance to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer: The Role of Cancer Stem Cells 56
Clinical pharmacology of monoclonal antibodies targeting anti-PD-1 axis in urothelial cancers 53
Early changes in plasma levels of mutant KRAS DNA as a sensitive marker of response to chemotherapy in pancreatic cancer 48
Should CYP2D6 be genotyped when treating with tamoxifen? 31
Should CYP2D6 be genotyped when treating with tamoxifen? [Letter in reply] 17
Totale 2.999
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.947
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.947
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020476 0 0 0 48 66 76 76 70 64 33 33 10
2020/2021238 16 18 7 17 11 12 19 14 42 15 30 37
2021/2022318 3 14 7 7 64 62 16 8 20 11 16 90
2022/2023587 59 85 45 32 49 60 1 40 148 5 61 2
2023/2024370 19 21 71 19 40 78 18 12 8 14 37 33
2024/202560 9 38 11 2 0 0 0 0 0 0 0 0
Totale 2.999